Human brain trauma severity is associated with lectin complement pathway activation.


Journal

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
ISSN: 1559-7016
Titre abrégé: J Cereb Blood Flow Metab
Pays: United States
ID NLM: 8112566

Informations de publication

Date de publication:
05 2019
Historique:
pubmed: 10 2 2018
medline: 28 4 2020
entrez: 10 2 2018
Statut: ppublish

Résumé

We explored the involvement of the lectin pathway of complement in post-traumatic brain injury (TBI) pathophysiology in humans. Brain samples were obtained from 28 patients who had undergone therapeutic contusion removal, within 12 h (early) or from >12 h until five days (late) from injury, and from five non-TBI patients. Imaging analysis indicated that lectin pathway initiator molecules (MBL, ficolin-1, ficolin-2 and ficolin-3), the key enzymes MASP-2 and MASP-3, and the downstream complement components (C3 fragments and TCC) were present inside and outside brain vessels in all contusions. Only ficolin-1 was found in the parenchyma of non-TBI tissues. Immunoassays in brain homogenates showed that MBL, ficolin-2 and ficolin-3 increased in TBI compared to non-TBI (2.0, 2.2 and 6.0-times) samples. MASP-2 increased with subarachnoid hemorrhage and abnormal pupil reactivity, two indicators of structural and functional damage. C3 fragments and TCC increased, respectively, by 3.5 - and 4.0-fold in TBI compared to non-TBI tissue and significantly correlated with MBL, ficolin-2, ficolin-3, MASP-2 and MASP-3 levels in the homogenates. In conclusion, we show for the first time the direct presence of lectin pathway components in human cerebral contusions and their association with injury severity, suggesting a central role for the lectin pathway in the post-traumatic pathophysiology of human TBI.

Identifiants

pubmed: 29425056
doi: 10.1177/0271678X18758881
pmc: PMC6501516
doi:

Substances chimiques

Complement C3 0
Lectins 0
Mannose-Binding Lectin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

794-807

Références

Diabetes. 2001 Jan;50(1):77-82
pubmed: 11147798
J Neurotrauma. 2001 Aug;18(8):773-81
pubmed: 11526983
J Neurotrauma. 2001 Dec;18(12):1295-311
pubmed: 11780861
Blood. 2003 Feb 1;101(3):1071-9
pubmed: 12393727
Int Immunol. 2003 Jan;15(1):109-17
pubmed: 12502731
J Immunol. 1992 Aug 15;149(4):1381-7
pubmed: 1386864
Exp Neurol. 2006 Jun;199(2):454-64
pubmed: 16545803
BMC Neurosci. 2006 Jul 14;7:55
pubmed: 16842619
Lancet Neurol. 2007 Jan;6(1):29-38
pubmed: 17166799
Trends Immunol. 2007 Apr;28(4):184-92
pubmed: 17336159
J Cereb Blood Flow Metab. 2007 Dec;27(12):1954-64
pubmed: 17457366
J Neuroinflammation. 2007 May 02;4:13
pubmed: 17474994
BMJ. 2008 Feb 23;336(7641):425-9
pubmed: 18270239
Lancet Neurol. 2008 Aug;7(8):728-41
pubmed: 18635021
PLoS Med. 2008 Aug 5;5(8):e165; discussion e165
pubmed: 18684008
Crit Care Med. 2009 Feb;37(2):659-65
pubmed: 19114897
J Neuroinflammation. 2009 Jan 08;6:2
pubmed: 19133139
J Neuropathol Exp Neurol. 2009 Sep;68(9):964-71
pubmed: 19680147
Immunobiology. 2010;215(1):1-11
pubmed: 19783065
Ann Neurol. 2009 Sep;66(3):332-42
pubmed: 19798727
Immunobiology. 2010 Nov;215(11):921-31
pubmed: 19939495
PLoS One. 2010 Feb 03;5(2):e8433
pubmed: 20140243
Lancet Neurol. 2010 May;9(5):543-54
pubmed: 20398861
Nat Immunol. 2010 Sep;11(9):785-97
pubmed: 20720586
Intensive Care Med. 2011 Feb;37(2):302-9
pubmed: 21072498
Int J Biochem Cell Biol. 2011 May;43(5):705-12
pubmed: 21315829
J Immunol. 2011 Oct 1;187(7):3751-8
pubmed: 21865552
Shock. 2012 Apr;37(4):348-54
pubmed: 22258234
J Neuroinflammation. 2012 Jun 21;9:137
pubmed: 22721265
Circulation. 2012 Sep 18;126(12):1484-94
pubmed: 22879370
Nat Rev Neurol. 2013 Apr;9(4):231-6
pubmed: 23443846
Scand J Immunol. 1985 Aug;22(2):197-202
pubmed: 2412280
Neurology. 2014 Jan 14;82(2):126-34
pubmed: 24336142
J Immunol. 2014 May 1;192(9):4352-60
pubmed: 24683193
Crit Care Med. 2014 Aug;42(8):1910-8
pubmed: 24810526
Front Cell Neurosci. 2014 Nov 07;8:380
pubmed: 25426028
Clin Chim Acta. 2015 Dec 7;451(Pt B):111-6
pubmed: 26525964
Proc Natl Acad Sci U S A. 2015 Nov 17;112(46):14319-24
pubmed: 26578778
J Neuroinflammation. 2015 Dec 01;12:226
pubmed: 26627059
J Neuroinflammation. 2016 Jan 20;13:16
pubmed: 26792363
JAMA Neurol. 2016 May 1;73(5):542-50
pubmed: 27019039
J Comp Pathol. 2016 May;154(4):323-8
pubmed: 27156898
J Cereb Blood Flow Metab. 2017 Mar;37(3):938-950
pubmed: 27165013
Sci Rep. 2016 Aug 18;6:31877
pubmed: 27535802
J Neuroinflammation. 2016 Aug 30;13(1):213
pubmed: 27577570
Immunol Rev. 2016 Nov;274(1):98-111
pubmed: 27782318
Immunol Rev. 2016 Nov;274(1):74-97
pubmed: 27782323
Stroke. 2016 Dec;47(12):3067-3073
pubmed: 27811336
Nat Rev Neurol. 2017 Mar;13(3):171-191
pubmed: 28186177
Front Immunol. 2017 Mar 16;8:288
pubmed: 28360913
J Neurotrauma. 2017 Sep;34(17):2560-2566
pubmed: 28482760
Anaesthesist. 1987 Jun;36(6):301-5
pubmed: 3498378
Scand J Immunol. 1985 Aug;22(2):183-95
pubmed: 4035298
J Neuroimmunol. 1997 Mar;73(1-2):63-9
pubmed: 9058760
J Neurotrauma. 1998 Oct;15(10):731-69
pubmed: 9814632

Auteurs

Daiana De Blasio (D)

1 IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.

Stefano Fumagalli (S)

1 IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.

Franca Orsini (F)

1 IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.

Laura Neglia (L)

1 IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.

Carlo Perego (C)

1 IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.

Fabrizio Ortolano (F)

2 Department of Anesthesia and Critical Care Medicine, Fondazione IRCCS Ca' Granda- Ospedale Maggiore Policlinico, Milano, Italy.

Elisa R Zanier (ER)

1 IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.

Edoardo Picetti (E)

3 Division of Anesthesia and Intensive Care, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.

Marco Locatelli (M)

4 Department of Neurosurgery, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milano, Italy.

Nino Stocchetti (N)

2 Department of Anesthesia and Critical Care Medicine, Fondazione IRCCS Ca' Granda- Ospedale Maggiore Policlinico, Milano, Italy.
5 Department of Physiopathology and Transplantation, Milan University, Milan, Italy.

Luca Longhi (L)

6 Department of Anesthesia and Critical Care Medicine, Neurosurgical Intensive Care Unit, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.

Peter Garred (P)

7 Laboratory of Molecular Medicine, Department of Clinical Immunology, Rigshospitalet Faculty of Medical and Health Sciences, University of Copenhagen, Copenhagen, Denmark.

Maria-Grazia De Simoni (MG)

1 IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH